Frequently Asked Questions
Find answers about our weight loss pharmacy services and treatments
Find answers about our weight loss pharmacy services and treatments
Our process is simple and physician-supervised:
Note: Some states require a video consultation with our physician.
Results vary by medication and individual. Zepbound may show up to 22.5% weight loss over 72 weeks, Wegovy ~14.9% over 68 weeks, Saxenda ~8% over 56 weeks, and Qsymia 7–11% over similar periods, when combined with lifestyle changes.
We prescribe FDA-approved medications including:
Our physicians determine the most appropriate medication based on your health profile.
Yes, combining medications like Zepbound, Wegovy, Saxenda, or Qsymia with a healthy diet and exercise enhances weight loss results. Consult your doctor for a personalized plan.
Yes, we accept prescription transfers from other pharmacies:
Controlled substances may require additional verification steps.
Visit our product page to learn about Zepbound, Wegovy, Saxenda, and Qsymia, and consult your doctor for a prescription. Sign up for our free guide to support your weight loss journey!
Yes , Currently, we only ship world wide to due to medication regulations. We’re unable to ship prescription medications internationally at this time.
For patients traveling abroad, we recommend:
We prioritize safety and discretion:
Side effects vary by medication but may include:
| Medication Type | Possible Side Effects |
|---|---|
| GLP-1 Agonists | Nausea, diarrhea, constipation, headache |
| Lipase Inhibitors | Oily spotting, gas, bowel urgency |
| Appetite Suppressants | Dry mouth, insomnia, increased heart rate |
Important: Contact us immediately for severe side effects like chest pain, vision changes, or allergic reactions.
We take medication safety seriously. To report side effects:
Our pharmacists will document your report and may contact your prescribing physician if adjustments are needed.
Tirzepatide (Zepbound) is a dual GIP/GLP-1 receptor agonist that suppresses appetite and improves metabolism. Clinical trials show it can achieve up to 22.5% average body weight loss over 72 weeks. Consult your doctor to see if it’s right for you.
Semaglutide (Wegovy) is a GLP-1 receptor agonist injected weekly. It reduces appetite and promotes satiety, leading to about 14.9% average weight loss over 68 weeks. Always consult a healthcare provider before starting.
Liraglutide (Saxenda) is a daily injectable GLP-1 agonist that helps reduce hunger, resulting in approximately 8% weight loss over 56 weeks. It’s designed to be used with diet and exercise for optimal results.
Qsymia is an oral combination pill that suppresses appetite and controls cravings, achieving 7–11% weight loss on average. It’s prescription-only and should be used under medical supervision.